Nano-X Imaging (NNOX) Stock Price, News & Analysis

Company Overview

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes. This architecture is intended to reduce manufacturing complexity and maintenance requirements compared with conventional X-ray devices. The company’s software suite offers tools for image enhancement, storage and remote review, supporting tele-radiology applications and cloud-based archiving of patient scans.

Founded in 2018 and headquartered in Israel, Nano-X Imaging completed a business combination via a special purpose acquisition company (SPAC) that resulted in its Nasdaq listing under the ticker NNOX in 2021. The company was co-founded by industry entrepreneur Ran Poliakine, who serves as chairman, and has attracted strategic partnerships to support clinical evaluation and regulatory submissions. Nano-X has secured CE marking for head and extremity imaging and has received Breakthrough Device designation from the U.S. Food and Drug Administration for its imaging system.

Nano-X Imaging is pursuing global commercialization through master distributor agreements and direct sales channels across Europe, the Middle East and Asia-Pacific regions. Initial distribution partnerships include territories such as Japan, Saudi Arabia, Italy and Spain, with further expansion plans targeting North America and other emerging markets. The company continues to engage healthcare providers and regulatory authorities to complete clinical validations and obtain market approvals.

Key Stats

• Today's Range: $1.92 to $1.97
• 50-Day Range: $1.63 to $2.85
• 52-Week Range: $1.59 to $5.72
• Volume: 1.22 million shs
• Average Volume: 1.22 million shs
• Market Capitalization: $133.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Moderate Buy

Nano-X Imaging Stock Analysis - MarketRank™

Nano-X Imaging scored higher than 77% of companies evaluated by MarketBeat, and ranked 112th out of 302 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nano-X Imaging has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 3 strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

Upside Potential

Nano-X Imaging has a consensus price target of $5.00, representing about 160.4% upside from its current price of $1.92.

Amount of Analyst Coverage

Nano-X Imaging has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nano-X Imaging are expected to grow in the coming year, from ($0.65) to ($0.38) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nano-X Imaging is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nano-X Imaging is -1.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nano-X Imaging has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

18.95% of the float of Nano-X Imaging has been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 9.59.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 7.85%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nano-X Imaging does not currently pay a dividend.

Dividend Growth

Nano-X Imaging does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: N/A

News Sentiment

Nano-X Imaging has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Nano-X Imaging this week, compared to 2 articles on an average week.

Search Interest

Only 10 people have searched for NNOX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

12 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nano-X Imaging insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.74% of the stock of Nano-X Imaging is held by insiders.

Percentage Held by Institutions

21.49% of the stock of Nano-X Imaging is held by institutions.

Company Calendar

• Last Earnings: 4/20/2026
• Today: 5/30/2026
• Next Earnings (Estimated): 7/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NNOX
• CIK: 1795251
• Web: www.nanox.vision
• Phone: 972-02-536-0360
• Fax: 972-02-544-5214
• Employees: 190
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Nano-X Imaging: $5.00
• High Price Target: $5.00
• Low Price Target: $5.00
• Potential Upside/Downside: +160.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.59)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$75.02 million
• Net Margins: -790.87%
• Pretax Margin: -589.89%
• Return on Equity: -64.65%
• Return on Assets: -57.27%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.96
• Quick Ratio: 3.77

Sales & Book Value

• Annual Sales: $13.02 million
• Price / Sales: 10.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.01 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 69,590,000
• Free Float: 64,204,000
• Market Cap: $133.61 million
• Optionable: Optionable
• Beta: 1.19